Transgenic Leishmania model for delta-aminolevulinate-inducible monospecific uroporphyria: cytolytic phototoxicity initiated by singlet oxygen-mediated inactivation of proteins and its ablation by endosomal mobilization of cytosolic uroporphyrin.
Inherent deficiencies of Leishmania in heme biosynthesis were genetically complemented for delta-aminolevulinate-inducible biosynthesis and accumulation of light-excitable uroporphyrin. The phototoxic flagellar immobilization and cytolysis phenotypes and porphyrin mobilization noted previously were further analyzed biochemically and cytologically to delineate the mechanism of phototoxicity and detoxification in this monoporphyric model. Under optimal conditions of induction for approximately 3 days, cells remained viable but became increasingly uroporphyric, peaking at > or =90% of the population by approximately day 2; thereafter, a small population of less porphyric or aporphyric cells emerged. On exposure to light, the flagella of porphyric cells were immobilized in milliseconds, and singlet oxygen became detectable in their lysates. Both photosensitive phenotypes increased proportionally with the cellular uroporphyric levels and were susceptible to inhibition by azide, but not by D-mannitol. Brief irradiation of the uroporphyric cells produced no appreciable protein degradation but inactivated cytosolic neomycin phosphotransferase and significantly bleached cytosolic green fluorescent protein, which was azide reversible. These cells were irreparably photodamaged, as indicated by their subsequent loss of membrane permeability and viability. This is the first in situ demonstration that early inactivation of functional proteins by singlet oxygen initiates the cytolytic phototoxicity in uroporphyria. Detoxification appears to involve endocytic/exocytic mobilization of uroporphyrin from cytosol to "porphyrinosomes" for its eventual extracellular expulsion. This is proposed as the sole mechanism of detoxification, since it is attributable to the reversion of porphyric to aporphyric cells during uroporphyrinogenesis and repeated cycles of this event plus photolysis selected no resistant mutants, only aporphyric clones of the parental phenotypes. Further characterization of the transport system for uroporphyrin in this model is expected to benefit not only our understanding of the cellular mechanism for disposal of toxic soluble wastes but also potentially the effective management of human uroporphyria and the use of uroporphyric Leishmania for vaccine/drug delivery.
Dutta
Sujoy
S
Department of Microbiology/Immunology, Chicago Medical School/Rosalind Franklin University, North Chicago, Illinois 60064, USA.
Kolli
Bala Krishna
BK
Tang
Aihua
A
Sassa
Shigeru
S
Chang
Kwang-Poo
KP
D000622:Aminolevulinic Acid / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics / Q000378:metabolism; D001386:Azides / Q000494:pharmacology; D001692:Biological Transport; D002463:Cell Membrane Permeability / Q000528:radiation effects; D002470:Cell Survival / Q000528:radiation effects; D003600:Cytosol / Q000378:metabolism*; D005407:Flagella / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007891:Leishmania / Q000187:drug effects / Q000235:genetics / Q000378:metabolism* / Q000528:radiation effects; D008027:Light; D023421:Models, Animal; D010641:Phenotype; D010782:Photolysis; D011164:Porphyrias / Q000139:chemically induced / Q000378:metabolism / Q000628:therapy; D011506:Proteins / Q000378:metabolism*; D026082:Singlet Oxygen / Q000378:metabolism*; D022161:Transport Vesicles / Q000378:metabolism; D014578:Uroporphyrins / Q000235:genetics / Q000378:metabolism* / Q000493:pharmacokinetics
D001386:Azides; D011506:Proteins; D014578:Uroporphyrins; D026082:Singlet Oxygen; D000622:Aminolevulinic Acid